Pacira reported $54.32M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Astellas Pharma JPY 140.34B 29.56B Jun/2025
Bristol-Myers Squibb USD 3.27B 1.63B Jun/2025
Ironwood Pharmaceuticals USD 32.05M 5.89M Dec/2024
J&J USD 7.88B 1.76B Mar/2025
Ligand Pharmaceuticals USD -40543000 50.88M Mar/2025
Novo Nordisk 38.28B 4.34B Jun/2025
Pacira USD 54.32M 24.98M Jun/2025
Perrigo USD 129.1M 1.9M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
Supernus Pharmaceuticals USD 41.47M 23.68M Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025
Xeris Pharmaceuticals USD 8.59M 2.87M Jun/2025
Zoetis USD 1.08B 110M Jun/2025